KEEP YOUR FINGER
ON THE PULSE

OF CONGESTIVE HEART FAILURE

The world's first miniature implant for left-atrial monitoring

The Advantage

Closed-loop CHF Therapy


VectoriousTM technology helps physicians to help patients help themselves. Via a simple, minimally-invasive implanted device, easy-to-access data and user-friendly external home-unit; the VectoriousTM system increases CHF patient quality of life and reduces readmission rates.

Daily 'push button' readings of patient hemodynamic pressure provide early, accurate physiological indication of cardiac decompensation. Patients enjoy ongoing, personalized care, physicians save lives and cut healthcare costs.

This medical device is not available for sale within the United States or internationally

Let's talk more about VectoriousTM!
Vectorious to Present at TCT 2015
01
SEP
2015

Vectorious at TCT 2015: Vectorious is pleased to have been selected for the Innovation Award Competition at the Transcatheter Cardiovascular Therapeutics (TCT) 2015 annual meeting. The TCT is the world's largest educational meeting specializing in interventional cardiovascular medicine, and will be held October 11-15 at the Moscone Convention Center in San Francisco, CA. The presentation, titled: “A Novel Left Atrial Pressure Monitoring System for Heart Failure” will take place on Tuesday, October 13th, at 8:59 AM.